INTRODUCTION {#s1}
============

Circular RNAs (circRNAs) are recently discovered noncoding RNAs that are highly represented in the eukaryotic transcriptome \[[@R1]\]. Previously regarded as splicing error byproducts \[[@R2]\], circRNAs are mainly formed by back-splicing of covalently jointed 3\`-and 5\`-ends \[[@R3]\]. Abundant expression of circRNAs that compete with endogenous RNAs has been reported \[[@R4]\]. To date, three types have been reported: circular intronic RNA, exonic circRNA and retained-intron circRNA \[[@R5]--[@R7]\]. Several functions have been identified for circRNAs, including RNA transport \[[@R8]\], protein binding \[[@R9]\] and regulation of translation \[[@R5]\]. In 2013, circRNAs were identified as efficient microRNA (miRNA) sponges \[[@R10], [@R11]\]. Endogenous linear RNAs have the ability to sequester and inhibit miRNA activity \[[@R12]\], indicting the existence of close interactions between circRNAs, miRNAs and mRNAs. Moreover, circRNAs have been associated with diseases, including Alzheimer disease, colorectal and ovarian cancer, idiopathic lung fibrosis and hepatocellular carcinoma \[[@R13]--[@R15]\].

The oncogenic retrovirus avian leukosis virus (ALV) causes a major infectious disease that leads to poor egg laying performance in chickens and impacts the poultry industry worldwide \[[@R16]\]. There are seven subgroups of ALV in chickens: ALV-A, -B, -C, -D, -E, -J and --K \[[@R17], [@R18]\]. ALV-J was first reported in commercial meat-type chickens in England in 1988 \[[@R19]\]. ALV infection spreads by horizontal transmission, vertical or congenital transmission and genetic transmission in flocks \[[@R20], [@R21]\]. Chickens infected with ALV-J can develop immunosuppression together with diverse tumors, such as myelocytomas, sarcomas, hemangiomas, nephromas and erythroblastosis, as well as myeloid leukosis, and the virus induces high mortality \[[@R22]--[@R24]\]. Up to now, no effective vaccine has been developed for ALV-J. The control and eradication of ALV-J from pedigree generations has become a priority in the breeder industry \[[@R25]\]. Breeding chickens that are naturally resistant to ALV-J infection is one potential control measure.

In a previous study, we bred ALV-J-resistant and -susceptible chickens and identified an anti-tumor gene by RNA sequencing \[[@R17]\]. To assess whether circRNAs are involved in resistance to ALV-J-induced tumor formation, tissue samples from ALV-J-resistant and -susceptible chickens were subjected to circRNA sequencing. The study lays the foundation of circRNAs may be used as a molecular marker of ALV-J-resistance in chickens and indicates circRNAs could play a role in cancer in chickens.

RESULTS {#s2}
=======

CircRNAs expression profiles {#s2_1}
----------------------------

In total, the numbers of reads from the three liver tissue samples from ALV-J-resistant chickens were 71314622, 69193854 and 71259856, resulting in mapped read counts of 55805408, 55911773 and 56634896 respectively (Figure [1A](#F1){ref-type="fig"}). The numbers of reads from the three tissue samples from ALV-J-susceptible chickens were 65310898, 64652876, 65505628, resulting in mapped read counts of 52943856, 52223375 and 52764699 respectively. Overall, over 1800 circRNAs were detected by circRNA sequencing; the Circos figure for the circRNAs in ALV-J-resistant and -susceptible chickens is shown in Figure [1B](#F1){ref-type="fig"}. In total, 32 significantly differentially expressed circRNAs were identified in ALV-J-resistant chickens compared to ALV-J-susceptible chickens. A heat map of the 32 differentially expressed circRNAs was generated to illustrate the distinguishable circRNA expression profiling of the samples (Figure [2](#F2){ref-type="fig"}); As shown in heat map, the number of 0.0, 1.83 and 2.91 on the top represents each circRNA expression level. The each row represents each circRNA and each column represents one sample. Dendrograms from clustering analysis of the samples are exhibited on the top. The left dendrogram separates the expression profiles of the resistant chickens group from the susceptible chickens group. Hierarchical clustering demonstrated the circRNA sequencing data was reliable.

![CircRNA sequencing data\
**(A)** Mapping region distribution within read alignments; **(B)** Circos plots, outline is the reference genome, inside is the chromosome coverage across all samples.](oncotarget-08-34961-g001){#F1}

![Heap map for the 32 significant differentially expressed circRNAs in ALV-J-resistant chickens\
Sample numbers \[[@R4]\], \[[@R3]\] and \[[@R26]\] represent ALV-J-resistant chickens; \[[@R8]\], \[[@R14]\] and \[[@R9]\] represent ALV-J-susceptible chickens. The numbers 0.0, 1.83 and 2.91 on the top represent the expression levels of the circRNAs. Each row represents a circRNA and each column represents one sample. Dendrograms produced by clustering analysis of the samples are shown on the top. Twelve circRNAs were upregulated (red) and 20 were downregulated (green) in ALV-J-resistant chickens compared to ALV-J-susceptible chickens.](oncotarget-08-34961-g002){#F2}

Differentially expressed circRNAs in ALV-J-resistant chickens {#s2_2}
-------------------------------------------------------------

Of the 32 significantly differentially expressed circRNAs, 12 circRNAs were upregulated and 20 were downregulated in ALV-J-resistant chickens compared to ALV-J-susceptible chickens. The 12 upregulated circRNAs in ALV-J-resistant chickens were ranked by fold change (FC), and the names of the best predicted transcript (parent gene) for each of these 12 circRNAs are shown in Table [1](#T1){ref-type="table"}.

###### The twelve significantly upregulated circRNAs linked to resistance to ALV-J induced tumor formation in chickens

  CircRNA ID                  *P*-value   Fold change   chrom   txStart     txEnd riginal   Original Gene
  --------------------------- ----------- ------------- ------- ----------- --------------- ---------------
  chr13:15110945-15122920-    0.0025      5.8790        chr13   15110944    15122920        JADE2
  chr9:22282452-22289593-     0.0050      4.2395        chr9    22282451    22289593        LEKR1
  chr19:6585504-6585731+      0.0062      4.0622        chr19   6585503     6585731         UbI
  chr3:105132799-105136715-   0.0297      3.8360        chr3    105132798   105136715       NCOA1
  chr1:179476699-179479760+   0.0114      3.4851        chr1    179476698   179479760       KDELC2
  chr15:469774-490727+        0.0166      3.2521        chr15   469773      490727          PPM1F
  chr1:194735582-194744050-   0.0291      3.1591        chr1    194735581   194744050       RAB6A
  chr18:11114003-11114452-    0.0367      2.9598        chr18   11114002    11114452        CASKIN2
  chr13:2807735-2827999-      0.0156      2.8263        chr13   2807734     2827999         RANBP17
  chr3:43666306-43724228-     0.0265      2.7662        chr3    43666305    43724228        PACRG
  chr23:5549365-5549645-      0.0334      2.6458        chr23   5549364     5549645         HMGCL
  chr2:816575-817682+         0.0031      2.5679        chr2    816574      817682          SMARCC1

The function analysis of miRNA target genes {#s2_3}
-------------------------------------------

GO annotation of the miRNA target genes predicted to be targeted by the 12 circRNAs that were upregulated in ALV-J-resistant chickens revealed the target genes were mainly involved in immune pathways (Figure [3](#F3){ref-type="fig"}), such as regulation of B cell activation, the immune response-activating cell surface receptor signaling pathway, B cell differentiation, alpha-beta T cell activation and positive regulation of mononuclear cell proliferation. KEGG pathway analysis of the predicted miRNA target genes is shown in Figure [4](#F4){ref-type="fig"}, three of the predicted miRNA target genes are associated with the mTOR signaling pathway.

![Annotated significant pathways targeted by the miRNA target genes of 12 circRNAs upregulated in ALV-J-resistant chickens\
The horizontal axis is the --LgP (logarithm of *P*-value) for the pathway and the vertical axis is the pathway category. *P* \< 0.05 was considered significant.](oncotarget-08-34961-g003){#F3}

![KEGG pathway analysis for the miRNA target genes of 12 circRNAs upregulated in ALV-J-resistant chickens\
The yellow boxes indicate the genes targeted by differentially expressed circRNAs.](oncotarget-08-34961-g004){#F4}

Validation of circRNA expression by qRT-PCR {#s2_4}
-------------------------------------------

Two randomly selected circRNAs that were upregulated in ALV-J-resistant chickens (chr1:194735582-194744050- and chr23:5549365-5549645-) and two randomly circRNAs that were downregulated in ALV-J-resistant chickens (chr8:1033880-1047222- and chr5:58225735-58230830-) were selected to validate the expression levels of the significantly differentially expressed circRNAs by quantitative real-time polymerase chain reaction (qRT-PCR). The qRT-PCR data for the four circRNAs was consistent with the trends observed using circRNA sequencing (Figure [5](#F5){ref-type="fig"}).

![Validation of the expression of four selected differentially expressed circRNAs identified by circRNA sequencing\
**(A)** Fold change for each circular RNA as indicated by circRNA sequencing; **(B)** Relative circRNA levels as indicated by qPCR. Bars are mean ± SD (n=3); \*\**P* \< 0.05.](oncotarget-08-34961-g005){#F5}

miRNA binding sites prediction and circRNA-targeted miRNA-gene network {#s2_5}
----------------------------------------------------------------------

CircRNAs with high number of target sites for a specific miRNA, the top 5 predicted miRNA targets of each circRNA were listed in Table [2](#T2){ref-type="table"}. We selected 3 differentially up-regulated circRNAs (chr3:43666306-43724228-, chr9:22282452-22289593- and chr3:105132799-105136715-) and constructed the CircRNA-targeted miRNA-gene network. Each circRNA had 5 predicted miRNA targets, every miRNA target had 10 predicted genes (Figure [6](#F6){ref-type="fig"}). The network showed that circRNA-targeted miRNA-gene had a strong connection with each other.

###### Predicted miRNAs for 12 differentially expressed circRNAs linked to resistance to ALV-J induced tumor formation in chickens

  CircRNA ID                  miRNA              miRNA             miRNA             miRNA              miRNA
  --------------------------- ------------------ ----------------- ----------------- ------------------ -----------------
  chr13:15110945-15122920-    gga-miR-6634-5p    gga-miR-1649-5p   gga-miR-24-3p     gga-miR-6587-3p    gga-miR-1663-3p
  chr9:22282452-22289593-     gga-miR-103-2-5p   gga-miR-107-5p    gga-miR-6680-3p   gga-miR-1692       gga-miR-6577-5p
  chr19:6585504-6585731+      gga-miR-3530-3p    gga-miR-6549-5p   gga-miR-1664-5p   gga-miR-1764-5p    gga-miR-193a-5p
  chr3:105132799-105136715-   gga-miR-7472-3p    gga-miR-138-5p    gga-miR-1625-3p   gga-miR-148a-5p    gga-miR-1680-5p
  chr1:179476699-179479760+   gga-miR-6632-5p    gga-miR-153-5p    gga-miR-1705      gga-miR-1684b-3p   gga-miR-6698-3p
  chr15:469774-490727+        gga-miR-2129       gga-miR-1632-5p   gga-miR-1659      gga-miR-6698-3p    gga-miR-6598-5p
  chr1:194735582-194744050-   gga-miR-6660-3p    gga-miR-1662      gga-miR-15c-5p    gga-miR-15b-5p     gga-miR-1787
  chr18:11114003-11114452-    gga-miR-6607-5p    gga-miR-1749-3p   gga-miR-1785      gga-miR-19b-5p     gga-miR-6545-3p
  chr13:2807735-2827999-      gga-miR-365b-5p    gga-miR-1756b     gga-miR-217-3p    gga-miR-6690-5p    gga-miR-1771
  chr3:43666306-43724228-     gga-miR-146c-3p    gga-miR-130c-5p   gga-miR-211       gga-miR-204        gga-miR-6641-5p
  chr23:5549365-5549645-      gga-miR-6702-5p    gga-miR-1662      gga-miR-34b-5p    gga-miR-6611-5p    gga-miR-6641-5p
  chr2:816575-817682+         gga-miR-6574-5p    gga-miR-6577-5p   gga-miR-1596-5p   gga-miR-1786       gga-miR-1615

![Predicted biomathematical circRNA-miRNA-gene network for three selected upregulated circRNAs in ALV-J-resistant chickens\
Yellow represents circRNAs, green represents miRNAs and pink represents miRNA target genes.](oncotarget-08-34961-g006){#F6}

DISCUSSION {#s3}
==========

ALV-J is a major pathogen with diverse pathotypes that leads to enormous economic losses. ALV-J has rapidly evolved with respect to its pathogenicity, host range and range of tumors induced \[[@R26]\]. ALV-J-induced tumors among layer-type chickens are one of the most important problems facing the global poultry industry \[[@R27]\]. Although the tumorigenic and pathogenic mechanisms of ALV-J remain unclear and are hot topics of research, no vaccine has been developed to control this disease; therefore, assessment of the host to identify genes associated with resistance to ALV-J-induced tumors may provide a novel method of controlling this problem. In this respect, we previously bred ALV-J-resistant and -susceptible chickens and discovered an anti-tumor gene by RNA sequencing \[[@R17]\].

CircRNAs are a recently discovered type of noncoding RNA that have attracted significant attention \[[@R28]\]. Numerous studies have identified hundreds and thousands of different circRNAs, mostly comprising one to several exons of protein coding genes \[[@R14]\], and circRNAs have been shown to regulate gene expression in mammals \[[@R9]\]. A recent publication indicated that circular RNA was enriched and stable in exosomes and could be a promising biomarker for cancer diagnosis \[[@R29]\], besides, Circular RNA expression alterations were also involved in disease occur and the detailed analysis methods of circRNA alterations were also illustrated \[[@R30]\]. MiRNAs are highly conversed during evolution and negatively regulate target mRNAs. Moreover, a previous study demonstrated that miRNAs play critical roles in tumor formation in chickens infected with ALV-J \[[@R31]\]. However, there is no data on the role of circRNAs in resistance to tumor formation induced by ALV-J or other pathogens in any species. In the current study, we assessed whether circRNAs are involved in resistance to ALV-J-induced tumor formation by analyzing circRNA expression in ALV-J-resistant and -susceptible chickens \[[@R17]\] using circRNA sequencing.

Gene ontology (GO) is a widely used bioinformatics concept that unifies the genes and gene products of all species \[[@R32]\]. High-throughput circRNA sequencing and real-time PCR are standardized approaches used to assess circRNA expression; these methods have been widely used to infer host gene expression in response to disease \[[@R33], [@R34]\]. Our study demonstrates circRNAs are differentially expressed in ALV-J-resistant chickens, including the 12 upregulated circRNAs, indicating circRNAs are involved in resistance to ALV-J-induced tumor formation. In 2011, an endogenous circRNA was found to be highly expressed in human and mouse brain tissues \[[@R35]\], but the function of this circRNA remained unknown. In 2013, circRNAs were identified as efficient microRNA (miRNA) sponges \[[@R10]\]. Overexpressing miRNA target site concatamers (miRNA sponges) results in loss of miRNA function accompanied by increased endogenous target gene expression \[[@R11]\]. Considering that circRNA can absorb miRNA and Go terms of miRNA target genes of 12 differentially expressed circRNAs that were upregulated in ALV-J-resistant chickens in this study are linked to immune pathways such as antigen receptor signaling pathway and regulation of B cell activation, besides, three of the predicted miRNA target genes in KEGG pathway are associated with the mTOR signaling pathway which is a key regulator of cell growth and proliferation and mTOR dysregulation has a key role to play in various cancers \[[@R36]\], so we suspect circRNAs could be involved in initiation of the immune effects that protect ALV-J-resistant chickens from infection and tumor formation. We propose circRNAs may represent a new mediator of tumor initiation and progression.

Further study of the functions of these circRNAs could improve our understanding of the mechanisms by which circRNAs confer resistance against ALV-J-induced tumor formation. This data also provides a basis for assessing the potential of the differentially expressed circRNAs as novel of biomarkers of resistance to ALV-J-induced tumor formation in chickens. Moreover, this study provides a solid theoretical foundation for further research into the molecular mechanisms by which circular RNAs play a role in the initiation and progression of cancer in chicken.

MATERIALS AND METHODS {#s4}
=====================

Ethics statement {#s4_1}
----------------

All experiments were carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The use of animals in this study was approved by South China Agricultural University Committee of Animal Experiments (approval ID: 201004152).

Samples and RNA isolation {#s4_2}
-------------------------

ALV-J-resistant and -susceptible chickens (F3 generation) were used as classical models of resistance or easily-induced tumors in response to ALV-J challenge \[[@R17]\]. The standard ALV-J NX0101 strain which induced myeloid tumors was used in this study. RNA was isolated from livers of three ALV-J-resistant and three ALV-J-susceptible chickens at 20 weeks after challenge with ALV-J. Total RNA was isolated from each group using TRizol reagent (Life Technologies, Carlsbad, CA, USA) according to the manufacturer\'s instructions. The concentration of the RNA samples was determined by assessing the OD260/280 using a NanoDrop ND-2000 instrument (Thermo, Waltham, MA, USA). The integrity of the RNA samples was assessed by denaturing agarose gel electrophoresis.

RNA library construction and circRNA sequencing {#s4_3}
-----------------------------------------------

Total RNA from each sample was used to prepare the circRNA sequencing library, via the following steps: 1) 5 μg total RNA samples were pretreated to enrich circRNAs using the CircRNA Enrichment Kit (Cloud-seq Inc., Shanghai, China). RNA libraries were constructed from the treated RNAs using the TruSeq Stranded Total RNA Library Prep Kit (Illumina, San Diego, CA, USA) according to the manufacturer\'s instructions. Libraries were controlled for quality and quantified using the BioAnalyzer 2100 system (Agilent Technologies, Inc., Santa Clara, CA, USA). The libraries were denatured as single-stranded DNA molecules, captured on Illumina flow cells, amplified *in situ* as clusters and finally sequenced for 150 cycles on an Illumina HiSeq Sequencer according to the manufacturer\'s instructions.

CircRNA sequencing analysis {#s4_4}
---------------------------

Paired-end reads were harvested from the Illumina HiSeq 4000 sequencer and quality controlled using Q30 \[[@R37]\]. After 3' adaptor-trimming and removal of low quality reads using Cutadapt software \[[@R38]\], the high quality trimmed reads were used for analysis of circRNAs. The high quality reads were aligned to the reference genome/transcriptome using bowtie2 software and circRNAs were detected and identified using find_circ software \[[@R39], [@R1]\]. Raw junction reads for all samples were normalized to the number of total mapped reads and log2 transformed. Circos software was used to construct the circos figure \[[@R40]\]. CircRNAs exhibiting fold changes ≥ 2.0 with *P*-values ≤ 0.05 were classified as significantly differentially expressed circRNAs.

Bioinformatic analysis and target prediction {#s4_5}
--------------------------------------------

CircRNA and miRNA interactions were predicted using customized Arraystar miRNA target prediction software based on TargetScan and miRanda \[[@R41], [@R42]\]; the top five putative target miRNAs were identified for upregulated circRNAs in ALV-J-resistant chickens. The putative target genes of these miRNAs were identified using Targetscan \[[@R41]\]. Cytoscape software was used to construct the circRNA-miRNA-gene networks \[[@R43]\]. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed for the differentially expressed circRNA-associated genes \[[@R44], [@R45]\].

Quantitative real-time polymerase chain reaction analysis {#s4_6}
---------------------------------------------------------

Total RNA was reverse transcribed to synthesize cDNA using PrimeScript RT Reagent Kit (Perfect Real Time; TaKaRa, Osaka, Japan) and subjected to quantitative real-time polymerase chain reaction (qRT-PCR) analysis on an Applied Biosystems 7500 Fast Real-Time PCR System (Roche, Basel, Switzerland; software version 2.0.5) with SYBR Green qPCR SMix (ROX; Roche). The primers used for the qRT-PCR analysis were: chr1:194735582-194744050- (F 5'-GGG CTTGTTTCTGGTTTGGGTTAG-3', R 5\`-AGTGTCCAT TGAGGAAGGAGAAAG-3\`), chr23:5549365-5549645- (F 5'-CTCCCTGTCTCCTCTCCCAATCTT-3', R 5'-CTC TGGTTCCTCTGTACTGCTGTATCC-3'), chr8:1033880- 1047222- (F 5'-GTTCCCCTAAGAAGCATTTGACAGA CT-3', R 5'-GGGATTAGAAGGAACTCCAGACACG -3'), chr5:58225735-58230830- (F 5'-CTTCAGGGCTT CATCTGCTCTC-3', R 5'-GACTCCATTACTCCAGAC AAAGTACG-3'), and β-actin mRNA (F 5'-GAAGT ACCCCATTGAACACGG-3', R 5'-AGGCATACAGGGA CAGCACA-3'). Three independent samples were analyzed for each group; all samples were assessed in triplicate. The 2^−ΔΔCt^ method was used to analyze the qPCR results \[[@R46]\].

Statistical analysis {#s4_7}
--------------------

Data are expressed as mean ± standard deviation (SD). The Student\'s *t-*test was used to assess differences among groups; *P* \< 0.05 was considered significant.
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